Trial · NCT00927186
Outcomes56
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 20 of 56
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Mineralizing Surface/Bone Surface (MS/BS) in the Cancellous Compartment (CC) of Iliac Crest Bone Biopsies at 6 Months | 6 months | All randomized participants who received at least one dose of study drug with an evaluable bone biopsy. | percentage of surface | MEDIAN |
| SECONDARY | Mineralizing Surface/Bone Surface (MS/BS) in the Cancellous Compartment (CC) of Iliac Crest Bone Biopsies at 24 Months | 24 months | All participants who received at least one dose of study drug with an evaluable bone biopsy and had MS/BS analysis of the CC at 24 months. | percentage of surface | MEDIAN |
| SECONDARY | Mineralizing Surface/Bone Surface(MS/BS) in the Endocortical Compartment (EC) of Iliac Crest Bone Biopsies at 6 and 24 Months | 6 and 24 months | All participants who received at least one dose of study drug with an evaluable bone biopsy and had MS/BS analysis of the EC at 6 and 24 months. | percentage of surface | MEDIAN |
| SECONDARY | Activation Frequency (Ac.f) in the Cancellous Compartment (CC) of Iliac Crest Bone Biopsies at 6 Months | 6 months | All randomized participants who received at least one dose of study drug with an evaluable bone biopsy. | new cycles/year | MEDIAN |
| SECONDARY | Activation Frequency (Ac.f) in the Cancellous Compartment (CC) of Iliac Crest Bone Biopsies at 24 Months | 24 months | All participants who received at least one dose of study drug with an evaluable bone biopsy and had Ac.f analysis of the CC at 24 months. | new cycles/year | MEDIAN |
| SECONDARY | Activation Frequency (Ac.f) in the Endocortical Compartment (EC) of Iliac Crest Bone Biopsies at 6 and 24 Months | 6 and 24 months | All participants who received at least one dose of study drug with an evaluable bone biopsy and had Ac.f analysis of the EC at 6 and 24 months. | new cycles/year | MEDIAN |
| SECONDARY | Bone Formation Rate (BFR) in the Cancellous Compartment (CC) of Iliac Crest Bone Biopsies at 6 Months | 6 months | All randomized participants who received at least one dose of study drug with an evaluable bone biopsy. | mm³/mm²/year | MEDIAN |
| SECONDARY | Bone Formation Rate (BFR) in the Cancellous Compartment (CC) of Iliac Crest Bone Biopsies at 24 Months | 24 months | All participants who received at least one dose of study drug with an evaluable bone biopsy and had BFR analysis of the CC at 24 months. | mm³/mm²/year | MEDIAN |
| SECONDARY | Bone Formation Rate (BFR) in the Endocortical Compartment (EC) of Iliac Crest Bone Biopsies at 6 and 24 Months | 6 and 24 months | All participants who received at least one dose of study drug with an evaluable bone biopsy and had BFR analysis of EC at 6 and 24 months. | mm³/mm²/year | MEDIAN |
| SECONDARY | Mineral Apposition Rate (MAR) in the Cancellous Compartment (CC) of Iliac Crest Bone Biopsies at 6 Months | 6 months | All randomized participants who received at least one dose of study drug with an evaluable bone biopsy. | micrometer (µm)/day | MEDIAN |
| SECONDARY | Mineral Apposition Rate (MAR) in the Cancellous Compartment (CC) of Iliac Crest Bone Biopsies at 24 Months | 24 months | All participants who received at least one dose of study drug with an evaluable bone biopsy and had MAR analysis of the CC at 24 months. | micrometer (µm)/day | MEDIAN |
| SECONDARY | Mineral Apposition Rate (MAR) in the Endocortical Compartment (EC) of Iliac Crest Bone Biopsies at 6 and 24 Months | 6 and 24 months | All participants who received at least one dose of study drug with an evaluable bone biopsy and had MAR analysis of the EC at 6 and 24 months. | micrometer (µm/day) | MEDIAN |
| SECONDARY | Adjusted Apposition Rate (Aj.AR) in the Cancellous Compartment (CC) of Iliac Crest Bone Biopsies at 6 Months | 6 months | All randomized participants who received at least one dose of study drug with an evaluable bone biopsy. | µm/day | MEDIAN |
| SECONDARY | Adjusted Apposition Rate (Aj.AR) in the Cancellous Compartment (CC) of Iliac Crest Bone Biopsies at 24 Months | 24 months | All participants who received at least one dose of study drug with an evaluable bone biopsy and had Aj.AR analysis of the CC at 24 months. | micrometer (µm)/day | MEDIAN |
| SECONDARY | Adjusted Apposition Rate (Aj.AR) in the Endocortical Compartment (EC) of Iliac Crest Bone Biopsies at 6 and 24 Months | 6 and 24 months | All participants who received at least one dose of study drug with an evaluable bone biopsy and had Aj.AR analysis of the EC at 6 and 24 months. | micrometer (µm)/day | MEDIAN |
| SECONDARY | Mineralization Lag Time (Mlt) in the Cancellous Compartment (CC) of Iliac Crest Bone Biopsies at 6 Months | 6 months | All randomized participants who received at least one dose of study drug with an evaluable bone biopsy. | day | MEDIAN |
| SECONDARY | Mineralization Lag Time (Mlt) in the Cancellous Compartment (CC) of Iliac Crest Bone Biopsies at 24 Months | 24 months | All participants who received at least one dose of study drug with an evaluable bone biopsy and had Mlt analysis of the CC at 24 months. | day | MEDIAN |
| SECONDARY | Mineralization Lag Time (Mlt) in the Endocortical Compartment (EC) of Iliac Crest Bone Biopsies at 6 and 24 Months | 6 and 24 months | All participants who received at least one dose of study drug with an evaluable bone biopsy and had Mlt analysis of the EC at 6 and 24 months. | day | MEDIAN |
| SECONDARY | Osteoid Maturation Time (Omt) in the Cancellous Compartment (CC) of Iliac Crest Bone Biopsies at 6 Months | 6 months | All randomized participants who received at least one dose of study drug with an evaluable bone biopsy. | day | MEDIAN |
| SECONDARY | Osteoid Maturation Time (Omt) in the Cancellous Compartment (CC) of Iliac Crest Bone Biopsies at 24 Months | 24 months | All participants who received at least one dose of study drug with an evaluable bone biopsy and had Omt analysis of the CC at 24 months. | day | MEDIAN |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00927186/outcomes